Skip to main content

Advertisement

SpringerLink
Log in

Mania and mortality: Why the excess cardiovascular risk in bipolar disorder?

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Individuals with bipolar disorder experience twice the cardiovascular mortality expected from general population estimates. The metabolic syndrome is more common in those with bipolar disorder, with a prevalence ratio of 1.6, and includes many traditional cardiovascular risk factors, which may explain much of the elevated risk. Manic symptom burden also predicts cardiovascular mortality, begging questions regarding other explanations for elevated cardiovascular risk. Ultimately, the mechanisms that lead to elevated cardiovascular risk in bipolar disorder are complex and potentially involve behavior, treatment, access to quality health care, and underlying pathophysiology. Much remains unknown about the etiology of any mechanisms inherent to illness or, for that matter, treatment effects. Addressing access and health behaviors can mitigate risk for individuals with bipolar disorder. Recent evidence indicates that psychiatrists are becoming aware of the vascular risk associated with bipolar disorder, although further education will improve monitoring and subsequent outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Weiner M, Warren L, Fiedorowicz JG: Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2009 (in press).

  2. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB: Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007, 68:899–907.

    Article  PubMed  Google Scholar 

  3. Angst F, Stassen HH, Clayton PJ, Angst J: Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord 2002, 68:167–181.

    Article  CAS  PubMed  Google Scholar 

  4. Weeke A, Vaeth M: Excess mortality of bipolar and unipolar manic-depressive patients. J Affect Disord 1986, 11:227–234.

    Article  CAS  PubMed  Google Scholar 

  5. Osby U, Brandt L, Correia N, et al.: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001, 58:844–850.

    Article  CAS  PubMed  Google Scholar 

  6. Tsuang MT, Woolson RF, Fleming JA: Causes of death in schizophrenia and manic-depression. Br J Psychiatry 1980, 136:239–242.

    Article  CAS  PubMed  Google Scholar 

  7. American Heart Association, National Heart, Lung, and Blood Institute, Grundy SM, et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005, 13:322–327.

    PubMed  Google Scholar 

  8. Cardenas J, Frye MA, Marusak SL, et al.: Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106:91–97.

    Article  PubMed  Google Scholar 

  9. Cassidy F, Ahearn E, Carroll MB: Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999, 156:1417–1420.

    CAS  PubMed  Google Scholar 

  10. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, et al.: Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008, 20:131–137.

    PubMed  Google Scholar 

  11. Toalson P, Ahmed S, Hardy T, Kabinoff G: The metabolic syndrome in patients with severe mental illnesses. Prim Care Companion J Clin Psychiatry 2004, 6:152–158.

    Article  PubMed  Google Scholar 

  12. Basu R, Brar JS, Chengappa KN, et al.: The prevalence of the metabolic syndrome in patients with schizoaffective disorder—bipolar subtype. Bipolar Disord 2004, 6:314–318.

    Article  PubMed  Google Scholar 

  13. Fagiolini A, Frank E, Scott JA, et al.: Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005, 7:424–430.

    Article  PubMed  Google Scholar 

  14. Yumru M, Savas HA, Kurt E, et al.: Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord 2007, 98:247–252.

    Article  CAS  PubMed  Google Scholar 

  15. Garcia-Portilla MP, Saiz PA, Benabarre A, et al.: The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106:197–201.

    Article  PubMed  Google Scholar 

  16. Teixeira PJ, Rocha FL: The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007, 29:330–336.

    Article  PubMed  Google Scholar 

  17. van Winkel R, De Hert M, Van Eyck D, et al.: Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008, 10:342–348.

    Article  PubMed  Google Scholar 

  18. Tirupati S, Chua LE: Obesity and metabolic syndrome in a psychiatric rehabilitation service. Aust N Z J Psychiatry 2007, 41:606–610.

    Article  PubMed  Google Scholar 

  19. Chang HH, Chou CH, Chen PS, et al.: High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009, 117:124–129.

    Article  CAS  PubMed  Google Scholar 

  20. Salvi V, Albert U, Chiarle A, et al.: Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008, 30:318–323.

    Article  PubMed  Google Scholar 

  21. Wilson PW, D’Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837–1847.

    CAS  PubMed  Google Scholar 

  22. Conroy RM, Pyorala K, Fitzgerald AP, et al.: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987–1003.

    Article  CAS  PubMed  Google Scholar 

  23. Garcia-Portilla MP, Saiz PA, Bascaran MT, et al.: Cardiovascular risk in patients with bipolar disorder. J Affect Disord 2009, 115:302–308.

    Article  PubMed  Google Scholar 

  24. Sajatovic M, Valenstein M, Blow FC, et al.: Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 2006, 8:232–241.

    Article  CAS  PubMed  Google Scholar 

  25. Frisancho AR: Reduced rate of fat oxidation: a metabolic pathway to obesity in the developing nations. Am J Hum Biol 2003, 15:522–532.

    Article  PubMed  Google Scholar 

  26. Fleet-Michaliszyn SB, Soreca I, Otto AD, et al.: A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects. J Clin Psychiatry 2008, 69:1892–1900.

    Article  PubMed  Google Scholar 

  27. Onyike CU, Crum RM, Lee HB, et al.: Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003, 158:1139–1147.

    Article  PubMed  Google Scholar 

  28. Carpenter KM, Hasin DS, Allison DB, Faith MS: Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000, 90:251–257.

    Article  CAS  PubMed  Google Scholar 

  29. Fiedorowicz JG, Solomon DA, Endicott J, et al.: Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009, 71:598–606.

    Article  PubMed  Google Scholar 

  30. Bradford DW, Kim MM, Braxton LE, et al.: Access to medical care among persons with psychotic and major affective disorders. Psychiatr Serv 2008, 59:847–852.

    Article  PubMed  Google Scholar 

  31. McAlpine DD, Mechanic D: Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk. Health Serv Res 2000, 35:277–292.

    CAS  PubMed  Google Scholar 

  32. Lasser K, Boyd JW, Woolhandler S, et al.: Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284:2606–2610.

    Article  CAS  PubMed  Google Scholar 

  33. Diaz FJ, James D, Botts S, et al.: Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord 2009, 11:154–165.

    Article  PubMed  Google Scholar 

  34. Chuang HT, Mansell C, Patten SB: Lifestyle characteristics of psychiatric outpatients. Can J Psychiatry 2008, 53:260–266.

    PubMed  Google Scholar 

  35. Newcomer JW: Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19(Suppl 1):1–93.

    CAS  PubMed  Google Scholar 

  36. Haddad PM, Sharma SG: Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 2007, 21:911–936.

    Article  CAS  PubMed  Google Scholar 

  37. Lakka HM, Laaksonen DE, Ladda TA, et al.: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709–2716.

    Article  PubMed  Google Scholar 

  38. Ray WA, Chung CP, Murray KT, et al.: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009, 360:225–235.

    Article  CAS  PubMed  Google Scholar 

  39. Hansen V, Jacobsen BK, Arnesen E: Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry 2001, 179:438–443.

    Article  CAS  PubMed  Google Scholar 

  40. Osby U, Correia N, Brandt L, et al.: Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 2000, 321:483–484.

    Article  CAS  PubMed  Google Scholar 

  41. Fiedorowicz JG, Palagummi NM, Behrendtsen O, Coryell WH: Cholesterol and affective morbidity. Psychiatry Res 2009 (in press).

  42. Vuksan-Cusa B, Marcinko D, Nad S, Jakovljevic M: Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:109–112.

    Article  CAS  PubMed  Google Scholar 

  43. Lowe GD: Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005, 3:1618–1627.

    Article  CAS  PubMed  Google Scholar 

  44. Huang TL, Lin FC: High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:370–372.

    Article  CAS  PubMed  Google Scholar 

  45. Dickerson F, Stallings C, Origoni A, et al.: Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:952–955.

    Article  CAS  PubMed  Google Scholar 

  46. Politi P, Brondino N, Emanuele E: Increased proapoptotic serum activity in patients with chronic mood disorders. Arch Med Res 2008, 39:242–245.

    Article  CAS  PubMed  Google Scholar 

  47. Correll CU: Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead? J Clin Psychiatry 2008, 69:1948–1952.

    Article  PubMed  Google Scholar 

  48. Shah A, Shen N, El-Mallakh RS: Weight gain occurs after onset of bipolar illness in overweight bipolar patients. Ann Clin Psychiatry 2006, 18:239–241.

    Article  PubMed  Google Scholar 

  49. Goldstein BI, Birmaher B, Axelson DA, et al.: Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry 2008, 69:1953–1959.

    Article  PubMed  Google Scholar 

  50. Kilbourne AM, Welsh D, McCarthy JF, et al.: Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med 2008, 23:1628–1633.

    Article  PubMed  Google Scholar 

  51. Kreyenbuhl J, Dickerson FB, Medoff DR, et al.: Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis 2006, 194:404–410.

    Article  PubMed  Google Scholar 

  52. Klemsdal TO, Holme I, Nerland H, et al.: Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009 Jun 5 (Epub ahead of print).

  53. Baynard T, Carhart RL Jr, Ploutz-Snyder LL, et al.: Shortterm training effects on diastolic function in obese persons with the metabolic syndrome. Obesity (Silver Spring) 2008, 16:1277–1283.

    Article  Google Scholar 

  54. Bauer M, Lecrubier Y, Suppes T: Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists. Eur Psychiatry 2008, 23:169–177.

    Article  PubMed  Google Scholar 

  55. Stahl SM, Mignon L, Meyer JM: Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand 2009, 119:171–179.

    Article  CAS  PubMed  Google Scholar 

  56. Morrato EH, Newcomer JW, Kamat S, et al.: Metabolic screening after the American Diabetes Association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care 2009, 32:1037–1042.

    Article  CAS  PubMed  Google Scholar 

  57. Gehi A, Haas D, Pipkin S, Whooley MA: Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005, 165:2508–2513.

    Article  PubMed  Google Scholar 

  58. Rieckmann N, Kronish IM, Haas D, et al.: Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006, 152:922–927.

    Article  PubMed  Google Scholar 

  59. Sajatovic M, Ignacio RV, West JA, et al.: Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry 2009, 50:100–107.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 200 Hawkins Drive W278GH, Iowa City, IA, 52242-1000, USA

    Jess G. Fiedorowicz

Authors
  1. Dylan P. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miriam Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maithri Prabhakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jess G. Fiedorowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jess G. Fiedorowicz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, D.P., Weiner, M., Prabhakar, M. et al. Mania and mortality: Why the excess cardiovascular risk in bipolar disorder?. Curr Psychiatry Rep 11, 475–480 (2009). https://doi.org/10.1007/s11920-009-0072-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-009-0072-3

Keywords

Search

Navigation